Global Market Research Report on Neuroprotective Products Market 2016 is a professional and in-depth complete study on the current state of the Neuroprotective Products worldwide.
Deerfield Beach, FL -- (SBWIRE) -- 07/14/2017 -- New report on Neuroprotective Products Market by Class of DrugsThe neuroprotective drugs are Cholinesterase inhibitors, NMDA receptor antagonists, Ion channel modulators, Anti-inflammatory and anti-apoptotic agents, Mitochondrial dysfunction regulators Neurotropic factors, Anti excitotoxic agents , Ion channel modulators, Metal Ion Chelators Free radical trappers, and others. The Cholinesterase inhibitors and NMDA receptor antagonists are used to treat Alzheimers. As the disease burden is high for this ailment, these drugs would command a major market share. However, the opportunity for emerging drugs is high, as CNS disorders involve an interplay of highly complex and multi- factorial processes & pathways. Therefore, investment in research and development would have high pay offs. Neuroprotective Market by GeographyThe market is segmented by geography into North America, Europe, Asia Pacific and RoW. In the United States, death due to Alzheimers increased by 68 percent during 2000 to 2010. According to the Parkinson Disease foundation, 60,000 Americans are diagnosed of Parkinsons each year. Hence, North America is the major market for these products. World –wide, an estimated five to seven million people are living with Parkinson disease, which would increase the demand for neuroprotective drugs and spur research and development. Europe and Asia Pacific would also see an increased demand as the cases for neurodegenerative diseases increases in these regions.
Get Free Sample Report Of Neuroprotective Products Market @ http://www.marketresearchstore.com/report/world-neuroprotective-products-market-opportunities-and-forecasts-68375#RequestSample
Neuroprotective Products Market by use in the treatment of Medical ConditionsThe neuroprotective drugs are used in the treatment of Alzheimer's disease, Multiple sclerosis, Parkinson's disease, Brain injury, Huntington's disease, Retinal disorders, Amyotrophic lateral sclerosis (ALS), Neuropathies, and other disorders affecting the nervous system.According to the Alzheimer's association, an estimated 5.2 million Americans have Alzheimer's and it is the 6th leading cause of death accounting for the death of more than 500,000 persons per year in the United States. Hence, the market for treatment of Alzheimers is huge and it would spur the development of neuroprotective drugs. Neuroprotective products are medications that protect the brain neurons from degeneration and injury. These products are used in the treatment of several central nervous system complications such as Parkinson's disease, Alzheimer's disease, and traumatic brain injuries among others. Neurodegenerative diseases and their prevalence increases significantly with age. Hence, the demand for neuroprotectives would increase in the future, as average life spans are increasing, which opens up a huge market for novel drugs for the treatment of these diseases. The drivers for this market are the increasing incidence and prevalence of neurodegenerative diseases, especially in aging populations and a need for the treatment of brain injuries caused chiefly by road accidents.
Do Inquiry To Buy Report Of Neuroprotective Products Market @ http://www.marketresearchstore.com/report/world-neuroprotective-products-market-opportunities-and-forecasts-68375#InquiryForBuying
Neuroprotective Products Market by Class of Drugs
NMDA receptor antagonists
Anti-inflammatory and anti-apoptotic agents
Mitochondrial dysfunction regulators
Metal Ion Chelators
Ion channel modulators
Ion channel modulators
Free radical trappers
Anti excitotoxic agents
Neuroprotective Products Market by use in the treatment of Medical Conditions
Ocular degeneration (retinal disorders)
Amyotrophic lateral sclerosis (ALS)
Other disorders affecting the nervous system.
Neuroprotective Market by Geography
Rest of the World